$0.1865
-0.0068-3.52%
al cierre: Nov 20, 4:00 PM EST
$0.1757
-0.0108-5.79%
After hour: Nov 20, 7:13 PM EST

The average analyst price target for Acumen Pharmaceuticals is $5.71, 3149.9% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $1 to $11. The latest change came on Nov 2, 2026, when BTIG lowered its price target on Acumen Pharmaceuticals from $8 to $1 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months